NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · IEX Real-Time Price · USD
7.96
+0.66 (9.04%)
Jul 19, 2024, 4:00 PM EDT - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $228.99 million as of July 22, 2024. Its market cap has increased by 122.11% in one year.
Market Cap
228.99M
Enterprise Value
243.01M
1-Year Change
122.11%
Ranking
Category
Stock Price
$7.96
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $228.99M, a decrease of -41.77%. That is a compound annual growth rate of -15.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 229.00M | -15.50% |
| Dec 29, 2023 | 271.00M | 630.46% |
| Dec 30, 2022 | 37.10M | -84.86% |
| Dec 31, 2021 | 245.10M | -37.68% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Semler Scientific | 236.92M |
| Gossamer Bio | 233.01M |
| Rezolute | 232.26M |
| Design Therapeutics | 229.93M |
| 2seventy bio | 229.78M |
| Delcath Systems | 228.68M |
| ESSA Pharma | 228.03M |
| Aldeyra Therapeutics | 226.96M |